Unknown

Dataset Information

0

Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers.


ABSTRACT: Nine dihydroartemisinin acetal dimers (6-14) with diversely functionalized linker units were synthesized and tested for in vitro antiprotozoal, anticancer and antimicrobial activity. Compounds 6, 7 and 11 [IC(50): 3.0-6.7 nM (D6) and 4.2-5.9 nM (W2)] were appreciably more active than artemisinin (1) [IC(50): 32.9 nM (D6) and 42.5 nM (W2)] against the chloroquine-sensitive (D6) and chloroquine-resistant (W2) strains of the malaria parasite, Plasmodium falciparum. Compounds 10, 13 and 14 displayed enhanced anticancer activity in a number of cell lines compared to the control drug, doxorubicin. The antifungal activity of 7 and 12 against Cryptococcus neoformans (IC(50): 0.16 and 0.55 microM, respectively) was also higher compared to the control drug, amphotericin B. The antileishmanial and antibacterial activities were marginal. A number of dihydroartemisinin acetal monomers (15-17) and a trimer (18) were isolated as byproducts from the dimer synthesis and were also tested for biological activity.

SUBMITTER: Slade D 

PROVIDER: S-EPMC2824924 | biostudies-literature | 2009 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers.

Slade Desmond D   Galal Ahmed M AM   Gul Waseem W   Radwan Mohamed M MM   Ahmed Safwat A SA   Khan Shabana I SI   Tekwani Babu L BL   Jacob Melissa R MR   Ross Samir A SA   Elsohly Mahmoud A MA  

Bioorganic & medicinal chemistry 20091030 23


Nine dihydroartemisinin acetal dimers (6-14) with diversely functionalized linker units were synthesized and tested for in vitro antiprotozoal, anticancer and antimicrobial activity. Compounds 6, 7 and 11 [IC(50): 3.0-6.7 nM (D6) and 4.2-5.9 nM (W2)] were appreciably more active than artemisinin (1) [IC(50): 32.9 nM (D6) and 42.5 nM (W2)] against the chloroquine-sensitive (D6) and chloroquine-resistant (W2) strains of the malaria parasite, Plasmodium falciparum. Compounds 10, 13 and 14 displayed  ...[more]

Similar Datasets

| S-EPMC6925292 | biostudies-literature
| S-EPMC9145871 | biostudies-literature
| S-EPMC3057096 | biostudies-literature
| S-EPMC10827920 | biostudies-literature
| S-EPMC1965449 | biostudies-literature
| S-EPMC6600397 | biostudies-literature
| S-EPMC7356147 | biostudies-literature
| S-EPMC9775310 | biostudies-literature
| S-EPMC7893584 | biostudies-literature
| S-EPMC10097620 | biostudies-literature